Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes

Figure 1

Drug mechanism of action of GLP-1 analogues, DPP-IV inhibitors, and GIP/GLP-1 receptor agonists.